Tapewire

NYSE · USD

OSCR

Oscar Health, Inc.

Export transactions ↓
Tapewire entity
3582
SEC CIK
0001568651
Parsed reports
314

Last 12 months

Inside the activity.

1 purchase rows · 62 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202506
Jan 202604
Feb 202600
Mar 202605
Apr 202610
May 202603
Jun 2026030
Jul 202603
Aug 202603
Sep 202606
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 01, 2022 Filed Jun 3, 2022 16:07 UTC
Quane Alessandrea C.EVP, Chief Insurance Officer
Exercise / conversionRestricted Stock Units · Derivative 7,016 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-004760 · primarydocument.xml · derivative · entry 3

Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,204

Underlying: Class A Common Stock · 7,016 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F4 · derivative.exercise_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021.

F4 · derivative.expiration_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 16:07 UTC
Quane Alessandrea C.EVP, Chief Insurance Officer
Exercise / conversionClass A Common Stock 7,016 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-22-004760 · primarydocument.xml · nonDerivative · entry 1

Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,624

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 20:08 UTC
Blackley Richard ScottChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 7,016 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-004761 · primarydocument.xml · derivative · entry 3

Blackley Richard Scott · CIK 0001525020 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,204

Underlying: Class A Common Stock · 7,016 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F4 · derivative.exercise_date: The restricted stock units vests in sixteen equal quarterly installments beginning on December 1, 2021.

F4 · derivative.expiration_date: The restricted stock units vests in sixteen equal quarterly installments beginning on December 1, 2021.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 20:08 UTC
Blackley Richard ScottChief Financial Officer
Exercise / conversionClass A Common Stock 7,016 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-22-004761 · primarydocument.xml · nonDerivative · entry 1

Blackley Richard Scott · CIK 0001525020 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 223,488

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 20:09 UTC
Bopitiya RanmaliEVP & Chief Legal Officer
Exercise / conversionRestricted Stock Units · Derivative 20,424 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-004764 · primarydocument.xml · derivative · entry 3

Bopitiya Ranmali · CIK 0001908069 · EVP & Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 306,373

Underlying: Class A Common Stock · 20,424 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F4 · derivative.exercise_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2022.

F4 · derivative.expiration_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2022.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 20:09 UTC
Bopitiya RanmaliEVP & Chief Legal Officer
Exercise / conversionClass A Common Stock 20,424 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-22-004764 · primarydocument.xml · nonDerivative · entry 1

Bopitiya Ranmali · CIK 0001908069 · EVP & Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,424

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 20:08 UTC
Weaver DennisChief Clinical Officer
Exercise / conversionRestricted Stock Units · Derivative 4,167 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-004762 · primarydocument.xml · derivative · entry 5

Weaver Dennis · CIK 0001844219 · Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,834

Underlying: Class A Common Stock · 4,167 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F5 · derivative.exercise_date: The restricted stock units vest in sixteen equal quarterly installments beginning on June 1, 2021.

F5 · derivative.expiration_date: The restricted stock units vest in sixteen equal quarterly installments beginning on June 1, 2021.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 20:08 UTC
Weaver DennisChief Clinical Officer
Exercise / conversionRestricted Stock Units · Derivative 2,004 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-004762 · primarydocument.xml · derivative · entry 4

Weaver Dennis · CIK 0001844219 · Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,059

Underlying: Class A Common Stock · 2,004 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F4 · derivative.exercise_date: The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021.

F4 · derivative.expiration_date: The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 20:08 UTC
Weaver DennisChief Clinical Officer
Exercise / conversionClass A Common Stock 4,167 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-22-004762 · primarydocument.xml · nonDerivative · entry 2

Weaver Dennis · CIK 0001844219 · Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,536

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 20:08 UTC
Weaver DennisChief Clinical Officer
Exercise / conversionClass A Common Stock 2,004 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-22-004762 · primarydocument.xml · nonDerivative · entry 1

Weaver Dennis · CIK 0001844219 · Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,369

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
April 15, 2022 Filed Apr 19, 2022 21:01 UTC GrantDeferred Stock Unit · Derivative 617 $8.91 $5,497.47
Disclosure

SEC source: 0001562180-22-003470 · primarydocument.xml · derivative · entry 1

PHILLIPS JR CHARLES E · CIK 0001236185 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 617

Underlying: Class A Common Stock · 617 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred stock unit represents a right to receive one share of the Company's Class A common stock.

F2 · price: The Reporting Person elected, pursuant to the Issuer's Deferred Compensation Plan for Directors, to receive deferred stock units in lieu of cash retainer payments for service on the Issuer's board of directors. The price of the deferred stock units reported herein represents the closing price of the Issuer's Class A Common Stock on April 14, 2022, which price was used to calculate the number of deferred stock units issued to the Reporting Person.

F3 · derivative.exercise_date: The deferred stock units will be settled for cash or shares of Class A common stock, in the Issuer's discretion, within 45 days of the first to occur of (i) termination of service; (ii) a change in control; (iii) death; or (iv) disability. Deferred stock units issued in lieu of cash retainer payment are 100% vested on the grant date.

F3 · derivative.expiration_date: The deferred stock units will be settled for cash or shares of Class A common stock, in the Issuer's discretion, within 45 days of the first to occur of (i) termination of service; (ii) a change in control; (iii) death; or (iv) disability. Deferred stock units issued in lieu of cash retainer payment are 100% vested on the grant date.

Read SEC document
April 15, 2022 Filed Apr 19, 2022 21:02 UTC GrantDeferred Stock Unit · Derivative 1,480 $8.91 $13,186.80
Disclosure

SEC source: 0001562180-22-003471 · primarydocument.xml · derivative · entry 1

BOYD JEFFERY H · CIK 0001214606 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,480

Underlying: Class A Common Stock · 1,480 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred stock unit represents a right to receive one share of the Company's Class A common stock.

F2 · price: The Reporting Person elected, pursuant to the Issuer's Deferred Compensation Plan for Directors, to receive deferred stock units in lieu of cash retainer payments for service on the Issuer's board of directors. The price of the deferred stock units reported herein represents the closing price of the Issuer's Class A Common Stock on April 14, 2022, which price was used to calculate the number of deferred stock units issued to the Reporting Person.

F3 · derivative.exercise_date: The deferred stock units will be settled for cash or shares of Class A Common common stock, in the Issuer's discretion, within 45 days of the first to occur of (i) termination of service (ii) a change in control (iii) death; or (iv) disability. Deferred stock units issued in lieu of cash retainer payment are 100% vested on the grant date.

F3 · derivative.expiration_date: The deferred stock units will be settled for cash or shares of Class A Common common stock, in the Issuer's discretion, within 45 days of the first to occur of (i) termination of service (ii) a change in control (iii) death; or (iv) disability. Deferred stock units issued in lieu of cash retainer payment are 100% vested on the grant date.

Read SEC document
March 10, 2022 Filed Mar 11, 2022 16:35 UTC
Quane Alessandrea C.EVP, Chief Insurance Officer
SaleClass A Common Stock 11,638 $8.30 $96,595.40
Disclosure

SEC source: 0001562180-22-002541 · primarydocument.xml · nonDerivative · entry 2

Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,608

F2 · shares: The sale was effected to satisfy the Reporting Person's tax withholding obligation upon the settlement of previously granted equity awards.

Read SEC document
March 09, 2022 Filed Mar 11, 2022 16:35 UTC
Quane Alessandrea C.EVP, Chief Insurance Officer
Exercise / conversionRestricted Stock Units · Derivative 31,250 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-002541 · primarydocument.xml · derivative · entry 3

Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 343,750

Underlying: Class A Common Stock · 31,250 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F3 · derivative.exercise_date: The restricted stock units vest with respect to 25% of the shares on December 5, 2021, and with respect to the remaining shares in 12 equal quarterly installments thereafter.

F3 · derivative.expiration_date: The restricted stock units vest with respect to 25% of the shares on December 5, 2021, and with respect to the remaining shares in 12 equal quarterly installments thereafter.

Read SEC document
March 09, 2022 Filed Mar 11, 2022 16:35 UTC
Quane Alessandrea C.EVP, Chief Insurance Officer
Exercise / conversionClass A Common Stock 31,250 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-22-002541 · primarydocument.xml · nonDerivative · entry 1

Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,246

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
March 08, 2022 Filed Mar 9, 2022 22:42 UTC
Blackley Richard ScottChief Financial Officer
SaleClass A Common Stock 19,204 $7.33 $140,845.98
Disclosure

SEC source: 0001562180-22-002490 · primarydocument.xml · nonDerivative · entry 2

Blackley Richard Scott · CIK 0001525020 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 216,472

F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.33 to $7.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Read SEC document
March 07, 2022 Filed Mar 9, 2022 22:42 UTC
Blackley Richard ScottChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 62,500 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-002490 · primarydocument.xml · derivative · entry 3

Blackley Richard Scott · CIK 0001525020 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 687,500

Underlying: Class A Common Stock · 62,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F4 · derivative.exercise_date: The restricted stock units vest with respect to 25% of the shares on December 5, 2021, and with respect to the remaining shares in 12 equal quarterly installments thereafter.

F4 · derivative.expiration_date: The restricted stock units vest with respect to 25% of the shares on December 5, 2021, and with respect to the remaining shares in 12 equal quarterly installments thereafter.

Read SEC document
March 07, 2022 Filed Mar 9, 2022 22:42 UTC
Blackley Richard ScottChief Financial Officer
Exercise / conversionClass A Common Stock 62,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-22-002490 · primarydocument.xml · nonDerivative · entry 1

Blackley Richard Scott · CIK 0001525020 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 235,676

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
March 02, 2022 Filed Mar 3, 2022 17:42 UTC
Quane Alessandrea C.EVP, Chief Insurance Officer
SaleClass A Common Stock 2,680 $6.92 $18,547.74
Disclosure

SEC source: 0001562180-22-002312 · primarydocument.xml · nonDerivative · entry 2

Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,996

F2 · shares: The sale was effected to satisfy the Reporting Person's tax withholding obligation upon the settlement of previously granted equity awards.

Read SEC document
March 02, 2022 Filed Mar 3, 2022 22:42 UTC
Blackley Richard ScottChief Financial Officer
SaleClass A Common Stock 2,605 $6.91 $18,009.67
Disclosure

SEC source: 0001562180-22-002311 · primarydocument.xml · nonDerivative · entry 2

Blackley Richard Scott · CIK 0001525020 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 173,176

F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards

Read SEC document
March 02, 2022 Filed Mar 3, 2022 22:42 UTC
Weaver DennisChief Clinical Officer
SaleClass A Common Stock 1,890 $6.94 $13,117.17
Disclosure

SEC source: 0001562180-22-002314 · primarydocument.xml · nonDerivative · entry 3

Weaver Dennis · CIK 0001844219 · Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,365

F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards

Read SEC document
March 02, 2022 Filed Mar 3, 2022 22:42 UTC
Joyce Meghan V.Chief Operating Officer
SaleClass A Common Stock 2,540 $6.91 $17,555.46
Disclosure

SEC source: 0001562180-22-002313 · primarydocument.xml · nonDerivative · entry 2

Joyce Meghan V. · CIK 0001770749 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,070

F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.9105 to $6.915, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 17:42 UTC
Quane Alessandrea C.EVP, Chief Insurance Officer
Exercise / conversionRestricted Stock Units · Derivative 7,016 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-002312 · primarydocument.xml · derivative · entry 3

Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,220

Underlying: Class A Common Stock · 7,016 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F3 · derivative.exercise_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021.

F3 · derivative.expiration_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 17:42 UTC
Quane Alessandrea C.EVP, Chief Insurance Officer
Exercise / conversionClass A Common Stock 7,016 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-22-002312 · primarydocument.xml · nonDerivative · entry 1

Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,676

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 22:42 UTC
Blackley Richard ScottChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 7,016 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-002311 · primarydocument.xml · derivative · entry 3

Blackley Richard Scott · CIK 0001525020 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,220

Underlying: Class A Common Stock · 7,016 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F3 · derivative.exercise_date: The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021.

F3 · derivative.expiration_date: The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 22:42 UTC
Blackley Richard ScottChief Financial Officer
Exercise / conversionClass A Common Stock 7,016 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-22-002311 · primarydocument.xml · nonDerivative · entry 1

Blackley Richard Scott · CIK 0001525020 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 175,781

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 22:42 UTC
Weaver DennisChief Clinical Officer
Exercise / conversionRestricted Stock Units · Derivative 2,005 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-002314 · primarydocument.xml · derivative · entry 5

Weaver Dennis · CIK 0001844219 · Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,064

Underlying: Class A Common Stock · 2,005 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F4 · derivative.exercise_date: The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021.

F4 · derivative.expiration_date: The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 22:42 UTC
Weaver DennisChief Clinical Officer
Exercise / conversionRestricted Stock Units · Derivative 4,166 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-002314 · primarydocument.xml · derivative · entry 4

Weaver Dennis · CIK 0001844219 · Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,001

Underlying: Class A Common Stock · 4,166 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F3 · derivative.exercise_date: The restricted stock units vest in sixteen equal quarterly installments beginning on June 1, 2021.

F3 · derivative.expiration_date: The restricted stock units vest in sixteen equal quarterly installments beginning on June 1, 2021.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 22:42 UTC
Weaver DennisChief Clinical Officer
Exercise / conversionClass A Common Stock 4,166 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-22-002314 · primarydocument.xml · nonDerivative · entry 2

Weaver Dennis · CIK 0001844219 · Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,255

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 22:42 UTC
Weaver DennisChief Clinical Officer
Exercise / conversionClass A Common Stock 2,005 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-22-002314 · primarydocument.xml · nonDerivative · entry 1

Weaver Dennis · CIK 0001844219 · Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,089

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 22:42 UTC
Joyce Meghan V.Chief Operating Officer
Exercise / conversionRestricted Stock Units · Derivative 7,016 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-002313 · primarydocument.xml · derivative · entry 4

Joyce Meghan V. · CIK 0001770749 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,220

Underlying: Class A Common Stock · 7,016 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F4 · derivative.exercise_date: The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021.

F4 · derivative.expiration_date: The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 22:42 UTC
Joyce Meghan V.Chief Operating Officer
Exercise / conversionClass A Common Stock 7,016 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-22-002313 · primarydocument.xml · nonDerivative · entry 1

Joyce Meghan V. · CIK 0001770749 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,610

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
February 16, 2022 Filed Feb 17, 2022 18:58 UTC
Quane Alessandrea C.EVP, Chief Insurance Officer
SaleClass A Common Stock 49,355 $7.18 $354,280.06
Disclosure

SEC source: 0001562180-22-001604 · primarydocument.xml · nonDerivative · entry 3

Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,660

F2 · shares: The sale was effected to satisfy the Reporting Person's tax withholding obligation upon the settlement of previously granted equity awards.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.12 to $7.2250, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 18:58 UTC
Quane Alessandrea C.EVP, Chief Insurance Officer
Exercise / conversionRestricted Stock Units · Derivative 7,015 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-001604 · primarydocument.xml · derivative · entry 5

Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,236

Underlying: Class A Common Stock · 7,015 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F5 · derivative.exercise_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021.

F5 · derivative.expiration_date: The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 18:58 UTC
Quane Alessandrea C.EVP, Chief Insurance Officer
Exercise / conversionRestricted Stock Units · Derivative 125,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-001604 · primarydocument.xml · derivative · entry 4

Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 375,000

Underlying: Class A Common Stock · 125,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F4 · derivative.exercise_date: The restricted stock units vested with respect to 25% of the shares on December 5, 2021, and vest with respect to the remaining shares in 12 equal quarterly installments thereafter.

F4 · derivative.expiration_date: The restricted stock units vested with respect to 25% of the shares on December 5, 2021, and vest with respect to the remaining shares in 12 equal quarterly installments thereafter.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 18:58 UTC
Quane Alessandrea C.EVP, Chief Insurance Officer
Exercise / conversionClass A Common Stock 7,015 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-22-001604 · primarydocument.xml · nonDerivative · entry 2

Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,015

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 18:58 UTC
Quane Alessandrea C.EVP, Chief Insurance Officer
Exercise / conversionClass A Common Stock 125,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-22-001604 · primarydocument.xml · nonDerivative · entry 1

Quane Alessandrea C. · CIK 0001667819 · EVP, Chief Insurance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
February 03, 2022 Filed Feb 7, 2022 16:05 UTC
Thrive Partners VII GP, LLCDirector · 10% owner
Claremount VII Associates, L.P.Director · 10% owner
Grant7.25% Convertible Senior Notes · Derivative 417,000 $417,000.00 Strike: $8.32 $173,889,000,000.00
Disclosure

SEC source: 0000899243-22-005007 · doc4.xml · derivative · entry 2

Thrive Partners VII Growth GP, LLC · CIK 0001877735 · Director · 10% owner

Thrive Capital Partners VII Growth, L.P. · CIK 0001841736 · Director · 10% owner

Thrive Partners VII GP, LLC · CIK 0001877733 · Director · 10% owner

Claremount VII Associates, L.P. · CIK 0001841808 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Claremount VII Associates, L.P.

Disclosed balance after: 417,000

Underlying: Class A Common Stock · 50,111 shares

Expires not disclosed

F1 · derivative.exercise_date: The 7.25% Convertible Senior Notes (the "Notes") are governed by an indenture (the "Indenture") between the Issuer and U.S. Bank National Association, as trustee (the "Trustee"). The Notes bear interest at a rate of 7.25% per annum, payable in cash, commencing on June 30, 2022. The Notes may be converted by the holder, subject to certain conditions, at an initial conversion price of approximately $8.32. Before August 31, 2031, holders of the Notes have the right to convert their Notes only upon the occurrence of certain events more fully described in the Indenture. From and after August 31, 2031, holders of the Notes may convert their Notes at any time at their election until the close of business on the second scheduled trading day immediately before the December 31, 2031 maturity date. Upon conversion, the Notes will be settled, at the Issuer's election, in shares of Class A Common Stock, cash, or a combination of cash and shares of Class A Common Stock,

F2 · derivative.exercise_date: (Continued from Footnote 1) subject to certain exceptions, including the right of the holder to elect to settle the Notes by Physical Settlement (as defined in the Indenture) upon conversion pursuant to the terms of the Investment Agreement, dated January 27, 2022, between the Issuer and the purchasers of the Notes. The conversion rate and conversion price are subject to customary adjustments upon the occurrence of certain events. Holders of the Notes have the right to require the Issuer to repurchase all or some of their Notes for cash, subject to certain conditions. The Notes are also subject to redemption under certain circumstances and include customary provisions relating to the occurrence of "Events of Default" (as defined in the Indenture). The Notes have a stated maturity of December 31, 2031, subject to earlier conversion, redemption or repurchase in accordance with their terms.

F1 · derivative.expiration_date: The 7.25% Convertible Senior Notes (the "Notes") are governed by an indenture (the "Indenture") between the Issuer and U.S. Bank National Association, as trustee (the "Trustee"). The Notes bear interest at a rate of 7.25% per annum, payable in cash, commencing on June 30, 2022. The Notes may be converted by the holder, subject to certain conditions, at an initial conversion price of approximately $8.32. Before August 31, 2031, holders of the Notes have the right to convert their Notes only upon the occurrence of certain events more fully described in the Indenture. From and after August 31, 2031, holders of the Notes may convert their Notes at any time at their election until the close of business on the second scheduled trading day immediately before the December 31, 2031 maturity date. Upon conversion, the Notes will be settled, at the Issuer's election, in shares of Class A Common Stock, cash, or a combination of cash and shares of Class A Common Stock,

F2 · derivative.expiration_date: (Continued from Footnote 1) subject to certain exceptions, including the right of the holder to elect to settle the Notes by Physical Settlement (as defined in the Indenture) upon conversion pursuant to the terms of the Investment Agreement, dated January 27, 2022, between the Issuer and the purchasers of the Notes. The conversion rate and conversion price are subject to customary adjustments upon the occurrence of certain events. Holders of the Notes have the right to require the Issuer to repurchase all or some of their Notes for cash, subject to certain conditions. The Notes are also subject to redemption under certain circumstances and include customary provisions relating to the occurrence of "Events of Default" (as defined in the Indenture). The Notes have a stated maturity of December 31, 2031, subject to earlier conversion, redemption or repurchase in accordance with their terms.

F4 · ownership.nature: Securities held directly by Claremount VII Associates, L.P. ("Claremount VII"). Thrive Partners VII GP, LLC ("Thrive Partners VII") is the general partner of Claremount VII. Joshua Kushner is the sole managing member of Thrive Partners VII and, in his capacity as managing member, has voting and investment power over the securities held by Claremount VII. Each of the foregoing entities and Mr. Kushner disclaim beneficial ownership of the shares held of record by Claremount VII except to the extent of their pecuniary interest therein.

Read SEC document
February 03, 2022 Filed Feb 7, 2022 16:05 UTC
Thrive Partners VII GP, LLCDirector · 10% owner
Claremount VII Associates, L.P.Director · 10% owner
Grant7.25% Convertible Senior Notes · Derivative 34,583,000 $34,583,000.00 Strike: $8.32 $1,195,983,889,000,000.00
Disclosure

SEC source: 0000899243-22-005007 · doc4.xml · derivative · entry 1

Thrive Partners VII Growth GP, LLC · CIK 0001877735 · Director · 10% owner

Thrive Capital Partners VII Growth, L.P. · CIK 0001841736 · Director · 10% owner

Thrive Partners VII GP, LLC · CIK 0001877733 · Director · 10% owner

Claremount VII Associates, L.P. · CIK 0001841808 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Thrive Capital Partners VII Growth, L.P.

Disclosed balance after: 34,583,000

Underlying: Class A Common Stock · 4,155,911 shares

Expires not disclosed

F1 · derivative.exercise_date: The 7.25% Convertible Senior Notes (the "Notes") are governed by an indenture (the "Indenture") between the Issuer and U.S. Bank National Association, as trustee (the "Trustee"). The Notes bear interest at a rate of 7.25% per annum, payable in cash, commencing on June 30, 2022. The Notes may be converted by the holder, subject to certain conditions, at an initial conversion price of approximately $8.32. Before August 31, 2031, holders of the Notes have the right to convert their Notes only upon the occurrence of certain events more fully described in the Indenture. From and after August 31, 2031, holders of the Notes may convert their Notes at any time at their election until the close of business on the second scheduled trading day immediately before the December 31, 2031 maturity date. Upon conversion, the Notes will be settled, at the Issuer's election, in shares of Class A Common Stock, cash, or a combination of cash and shares of Class A Common Stock,

F2 · derivative.exercise_date: (Continued from Footnote 1) subject to certain exceptions, including the right of the holder to elect to settle the Notes by Physical Settlement (as defined in the Indenture) upon conversion pursuant to the terms of the Investment Agreement, dated January 27, 2022, between the Issuer and the purchasers of the Notes. The conversion rate and conversion price are subject to customary adjustments upon the occurrence of certain events. Holders of the Notes have the right to require the Issuer to repurchase all or some of their Notes for cash, subject to certain conditions. The Notes are also subject to redemption under certain circumstances and include customary provisions relating to the occurrence of "Events of Default" (as defined in the Indenture). The Notes have a stated maturity of December 31, 2031, subject to earlier conversion, redemption or repurchase in accordance with their terms.

F1 · derivative.expiration_date: The 7.25% Convertible Senior Notes (the "Notes") are governed by an indenture (the "Indenture") between the Issuer and U.S. Bank National Association, as trustee (the "Trustee"). The Notes bear interest at a rate of 7.25% per annum, payable in cash, commencing on June 30, 2022. The Notes may be converted by the holder, subject to certain conditions, at an initial conversion price of approximately $8.32. Before August 31, 2031, holders of the Notes have the right to convert their Notes only upon the occurrence of certain events more fully described in the Indenture. From and after August 31, 2031, holders of the Notes may convert their Notes at any time at their election until the close of business on the second scheduled trading day immediately before the December 31, 2031 maturity date. Upon conversion, the Notes will be settled, at the Issuer's election, in shares of Class A Common Stock, cash, or a combination of cash and shares of Class A Common Stock,

F2 · derivative.expiration_date: (Continued from Footnote 1) subject to certain exceptions, including the right of the holder to elect to settle the Notes by Physical Settlement (as defined in the Indenture) upon conversion pursuant to the terms of the Investment Agreement, dated January 27, 2022, between the Issuer and the purchasers of the Notes. The conversion rate and conversion price are subject to customary adjustments upon the occurrence of certain events. Holders of the Notes have the right to require the Issuer to repurchase all or some of their Notes for cash, subject to certain conditions. The Notes are also subject to redemption under certain circumstances and include customary provisions relating to the occurrence of "Events of Default" (as defined in the Indenture). The Notes have a stated maturity of December 31, 2031, subject to earlier conversion, redemption or repurchase in accordance with their terms.

F3 · ownership.nature: Securities held directly by Thrive Capital Partners VII Growth, L.P. ("Thrive VII Growth"). Thrive Partners VII Growth GP, LLC ("Thrive Partners VII Growth") is the general partner of Thrive VII Growth. Joshua Kushner is the sole managing member of Thrive Partners VII Growth and, in his capacity as managing member, has voting and investment power over the securities held by Thrive VII Growth. Each of the foregoing entities and Mr. Kushner disclaim beneficial ownership of the shares held of record by Thrive VII Growth except to the extent of their pecuniary interest therein.

Read SEC document
February 03, 2022 Filed Feb 7, 2022 21:05 UTC
Kushner JoshuaDirector · Co-Founder and Vice Chairman · 10% owner
Grant7.25% Convertible Senior Notes · Derivative 417,000 $417,000.00 Strike: $8.32 $173,889,000,000.00
Disclosure

SEC source: 0000899243-22-005008 · doc4.xml · derivative · entry 2

Kushner Joshua · CIK 0001844181 · Director · Co-Founder and Vice Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Claremount VII Associates, L.P.

Disclosed balance after: 417,000

Underlying: Class A Common Stock · 50,111 shares

Expires not disclosed

F1 · derivative.exercise_date: The 7.25% Convertible Senior Notes (the "Notes") are governed by an indenture (the "Indenture") between the Issuer and U.S. Bank National Association, as trustee (the "Trustee"). The Notes bear interest at a rate of 7.25% per annum, payable in cash, commencing on June 30, 2022. The Notes may be converted by the holder, subject to certain conditions, at an initial conversion price of approximately $8.32. Before August 31, 2031, holders of the Notes have the right to convert their Notes only upon the occurrence of certain events more fully described in the Indenture. From and after August 31, 2031, holders of the Notes may convert their Notes at any time at their election until the close of business on the second scheduled trading day immediately before the December 31, 2031 maturity date. Upon conversion, the Notes will be settled, at the Issuer's election, in shares of Class A Common Stock, cash, or a combination of cash and shares of Class A Common Stock,

F2 · derivative.exercise_date: (Continued from Footnote 1) subject to certain exceptions, including the right of the holder to elect to settle the Notes by Physical Settlement (as defined in the Indenture) upon conversion pursuant to the terms of the Investment Agreement, dated January 27, 2022, between the Issuer and the purchasers of the Notes. The conversion rate and conversion price are subject to customary adjustments upon the occurrence of certain events. Holders of the Notes have the right to require the Issuer to repurchase all or some of their Notes for cash, subject to certain conditions. The Notes are also subject to redemption under certain circumstances and include customary provisions relating to the occurrence of "Events of Default" (as defined in the Indenture). The Notes have a stated maturity of December 31, 2031, subject to earlier conversion, redemption or repurchase in accordance with their terms.

F1 · derivative.expiration_date: The 7.25% Convertible Senior Notes (the "Notes") are governed by an indenture (the "Indenture") between the Issuer and U.S. Bank National Association, as trustee (the "Trustee"). The Notes bear interest at a rate of 7.25% per annum, payable in cash, commencing on June 30, 2022. The Notes may be converted by the holder, subject to certain conditions, at an initial conversion price of approximately $8.32. Before August 31, 2031, holders of the Notes have the right to convert their Notes only upon the occurrence of certain events more fully described in the Indenture. From and after August 31, 2031, holders of the Notes may convert their Notes at any time at their election until the close of business on the second scheduled trading day immediately before the December 31, 2031 maturity date. Upon conversion, the Notes will be settled, at the Issuer's election, in shares of Class A Common Stock, cash, or a combination of cash and shares of Class A Common Stock,

F2 · derivative.expiration_date: (Continued from Footnote 1) subject to certain exceptions, including the right of the holder to elect to settle the Notes by Physical Settlement (as defined in the Indenture) upon conversion pursuant to the terms of the Investment Agreement, dated January 27, 2022, between the Issuer and the purchasers of the Notes. The conversion rate and conversion price are subject to customary adjustments upon the occurrence of certain events. Holders of the Notes have the right to require the Issuer to repurchase all or some of their Notes for cash, subject to certain conditions. The Notes are also subject to redemption under certain circumstances and include customary provisions relating to the occurrence of "Events of Default" (as defined in the Indenture). The Notes have a stated maturity of December 31, 2031, subject to earlier conversion, redemption or repurchase in accordance with their terms.

F4 · ownership.nature: Securities held directly by Claremount VII Associates, L.P. ("Claremount VII"). Thrive Partners VII GP, LLC ("Thrive Partners VII") is the general partner of Claremount VII. Joshua Kushner is the sole managing member of Thrive Partners VII and, in his capacity as managing member, has voting and investment power over the securities held by Claremount VII. Each of the foregoing entities and Mr. Kushner disclaim beneficial ownership of the shares held of record by Claremount VII except to the extent of their pecuniary interest therein.

Read SEC document
February 03, 2022 Filed Feb 7, 2022 21:05 UTC
Kushner JoshuaDirector · Co-Founder and Vice Chairman · 10% owner
Grant7.25% Convertible Senior Notes · Derivative 34,583,000 $34,583,000.00 Strike: $8.32 $1,195,983,889,000,000.00
Disclosure

SEC source: 0000899243-22-005008 · doc4.xml · derivative · entry 1

Kushner Joshua · CIK 0001844181 · Director · Co-Founder and Vice Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Thrive Capital Partners VII Growth, L.P.

Disclosed balance after: 34,583,000

Underlying: Class A Common Stock · 4,155,911 shares

Expires not disclosed

F1 · derivative.exercise_date: The 7.25% Convertible Senior Notes (the "Notes") are governed by an indenture (the "Indenture") between the Issuer and U.S. Bank National Association, as trustee (the "Trustee"). The Notes bear interest at a rate of 7.25% per annum, payable in cash, commencing on June 30, 2022. The Notes may be converted by the holder, subject to certain conditions, at an initial conversion price of approximately $8.32. Before August 31, 2031, holders of the Notes have the right to convert their Notes only upon the occurrence of certain events more fully described in the Indenture. From and after August 31, 2031, holders of the Notes may convert their Notes at any time at their election until the close of business on the second scheduled trading day immediately before the December 31, 2031 maturity date. Upon conversion, the Notes will be settled, at the Issuer's election, in shares of Class A Common Stock, cash, or a combination of cash and shares of Class A Common Stock,

F2 · derivative.exercise_date: (Continued from Footnote 1) subject to certain exceptions, including the right of the holder to elect to settle the Notes by Physical Settlement (as defined in the Indenture) upon conversion pursuant to the terms of the Investment Agreement, dated January 27, 2022, between the Issuer and the purchasers of the Notes. The conversion rate and conversion price are subject to customary adjustments upon the occurrence of certain events. Holders of the Notes have the right to require the Issuer to repurchase all or some of their Notes for cash, subject to certain conditions. The Notes are also subject to redemption under certain circumstances and include customary provisions relating to the occurrence of "Events of Default" (as defined in the Indenture). The Notes have a stated maturity of December 31, 2031, subject to earlier conversion, redemption or repurchase in accordance with their terms.

F1 · derivative.expiration_date: The 7.25% Convertible Senior Notes (the "Notes") are governed by an indenture (the "Indenture") between the Issuer and U.S. Bank National Association, as trustee (the "Trustee"). The Notes bear interest at a rate of 7.25% per annum, payable in cash, commencing on June 30, 2022. The Notes may be converted by the holder, subject to certain conditions, at an initial conversion price of approximately $8.32. Before August 31, 2031, holders of the Notes have the right to convert their Notes only upon the occurrence of certain events more fully described in the Indenture. From and after August 31, 2031, holders of the Notes may convert their Notes at any time at their election until the close of business on the second scheduled trading day immediately before the December 31, 2031 maturity date. Upon conversion, the Notes will be settled, at the Issuer's election, in shares of Class A Common Stock, cash, or a combination of cash and shares of Class A Common Stock,

F2 · derivative.expiration_date: (Continued from Footnote 1) subject to certain exceptions, including the right of the holder to elect to settle the Notes by Physical Settlement (as defined in the Indenture) upon conversion pursuant to the terms of the Investment Agreement, dated January 27, 2022, between the Issuer and the purchasers of the Notes. The conversion rate and conversion price are subject to customary adjustments upon the occurrence of certain events. Holders of the Notes have the right to require the Issuer to repurchase all or some of their Notes for cash, subject to certain conditions. The Notes are also subject to redemption under certain circumstances and include customary provisions relating to the occurrence of "Events of Default" (as defined in the Indenture). The Notes have a stated maturity of December 31, 2031, subject to earlier conversion, redemption or repurchase in accordance with their terms.

F3 · ownership.nature: Securities held directly by Thrive Capital Partners VII Growth, L.P. ("Thrive VII Growth"). Thrive Partners VII Growth GP, LLC ("Thrive Partners VII Growth") is the general partner of Thrive VII Growth. Joshua Kushner is the sole managing member of Thrive Partners VII Growth and, in his capacity as managing member, has voting and investment power over the securities held by Thrive VII Growth. Each of the foregoing entities and Mr. Kushner disclaim beneficial ownership of the shares held of record by Thrive VII Growth except to the extent of their pecuniary interest therein.

Read SEC document
December 07, 2021 Filed Dec 7, 2021 22:16 UTC
Blackley Richard ScottChief Financial Officer
SaleClass A Common Stock 86,160 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-21-007538 · primarydocument.xml · nonDerivative · entry 2

Blackley Richard Scott · CIK 0001525020 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 168,765

F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.76 to $10.045, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Read SEC document
December 05, 2021 Filed Dec 7, 2021 22:16 UTC
Blackley Richard ScottChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 250,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-007538 · primarydocument.xml · derivative · entry 3

Blackley Richard Scott · CIK 0001525020 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 750,000

Underlying: Class A Common Stock · 250,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F4 · derivative.exercise_date: The restricted stock units vest with respect to 25% of the shares on December 5, 2021, and with respect to the remaining shares in 12 equal quarterly installments thereafter.

F4 · derivative.expiration_date: The restricted stock units vest with respect to 25% of the shares on December 5, 2021, and with respect to the remaining shares in 12 equal quarterly installments thereafter.

Read SEC document
December 05, 2021 Filed Dec 7, 2021 22:16 UTC
Blackley Richard ScottChief Financial Officer
Exercise / conversionClass A Common Stock 250,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-21-007538 · primarydocument.xml · nonDerivative · entry 1

Blackley Richard Scott · CIK 0001525020 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 254,925

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
December 02, 2021 Filed Dec 3, 2021 22:10 UTC
Blackley Richard ScottChief Financial Officer
SaleClass A Common Stock 2,090 $8.81 $18,413.95
Disclosure

SEC source: 0001562180-21-007448 · primarydocument.xml · nonDerivative · entry 2

Blackley Richard Scott · CIK 0001525020 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,925

F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the settlement of previously granted equity awards

Read SEC document
December 02, 2021 Filed Dec 3, 2021 22:11 UTC
Weaver DennisChief Clinical Officer
SaleClass A Common Stock 2,410 $8.79 $21,171.85
Disclosure

SEC source: 0001562180-21-007450 · primarydocument.xml · nonDerivative · entry 3

Weaver Dennis · CIK 0001844219 · Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,084

F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards

Read SEC document
December 02, 2021 Filed Dec 3, 2021 22:11 UTC
Joyce Meghan V.Chief Operating Officer
SaleClass A Common Stock 3,090 $8.75 $27,037.50
Disclosure

SEC source: 0001562180-21-007449 · primarydocument.xml · nonDerivative · entry 2

Joyce Meghan V. · CIK 0001770749 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,594

F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards

Read SEC document
December 01, 2021 Filed Dec 3, 2021 22:10 UTC
Blackley Richard ScottChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 7,015 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-007448 · primarydocument.xml · derivative · entry 3

Blackley Richard Scott · CIK 0001525020 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,236

Underlying: Class A Common Stock · 7,015 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F3 · derivative.exercise_date: The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021.

F3 · derivative.expiration_date: The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021.

Read SEC document
December 01, 2021 Filed Dec 3, 2021 22:10 UTC
Blackley Richard ScottChief Financial Officer
Exercise / conversionClass A Common Stock 7,015 Not disclosed Not disclosed
Disclosure

SEC source: 0001562180-21-007448 · primarydocument.xml · nonDerivative · entry 1

Blackley Richard Scott · CIK 0001525020 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,015

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
December 01, 2021 Filed Dec 3, 2021 22:11 UTC
Weaver DennisChief Clinical Officer
Exercise / conversionRestricted Stock Units · Derivative 2,004 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-007450 · primarydocument.xml · derivative · entry 5

Weaver Dennis · CIK 0001844219 · Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,068

Underlying: Class A Common Stock · 2,004 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F4 · derivative.exercise_date: The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021.

F4 · derivative.expiration_date: The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.